{
  "authors": [
    {
      "author": "Said Farschtschi"
    },
    {
      "author": "Victor-Felix Mautner"
    },
    {
      "author": "Silke Hollants"
    },
    {
      "author": "Christian Hagel"
    },
    {
      "author": "Marijke Spaepen"
    },
    {
      "author": "Christoph Schulte"
    },
    {
      "author": "Eric Legius"
    },
    {
      "author": "Hilde Brems"
    }
  ],
  "doi": "10.1186/s12881-015-0146-5",
  "publication_date": "2015-05-01",
  "id": "EN115321",
  "url": "https://pubmed.ncbi.nlm.nih.gov/25928347",
  "source": "BMC medical genetics",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "In this study we present a patient with hyper- and hypopigmented regions, verrucous pigmented skin lesions and a paravertebral conglomerate tumour at the level of the cervical and thoracic spine. A large lipomatous dumbbell tumour caused atrophy of the spinal cord with progressive paraparesis. We identified a mosaic c.35G > A (p.Gly12Asp) KRAS mutation in the pigmented verrucous epidermal nevus tissue, the intraneural schwann cells and the lipoma. The c.35G > A (p.Gly12Asp) KRAS mutation was absent in the peripheral blood leukocytes."
}